View Older Stories View More Recent Stories
-
Dollar weakens as bond yields retreat after rapid rise
-
KemPharm (KMPH) Prices 8.33M Share Common Offering at $3/Sh
-
KemPharm Announces Pricing of Public Offering of Common Stock
-
Azure Power (AZRE) Prices 14.8M Share Offering at $12.50/Sh
-
Azure Power Announces Pricing of Public Offering of 14,800,000 Equity Shares
-
VEREIT, Inc. Announces Pricing of $550 Million of Senior Notes
-
KemPharm (KMPH) to Offer Common Stock
-
KemPharm Announces Proposed Public Offering of Common Stock
-
Monmouth Real Estate (MNR) Prices 8M Share Common Stock Offering at $15/sh
-
Monmouth Real Estate Investment Corporation Announces Pricing of Common Stock Offering
-
Government Properties Income Trust Sells Common Shares of Select Income REIT
-
Government Properties Income Trust Sells Common Shares of Select Income REIT
-
Repligen (RGEN) Fair Value Target Raised to $70 at Janney Montgomery Scott
-
THL Credit Announces Public Offering of Notes due 2023
-
THL Credit Announces Public Offering of Notes due 2023
-
West Pharmaceutical (WST) PT Raised to $140 at Janney
-
THL Credit Announces Public Offering
-
THL Credit Announces Public Offering
-
Ampco-Pittsburgh (AP) PT Lowered to $5 at Janney Montgomery Scott
-
Recro Pharma (REPH) PT Raised to $13 at Janney Montgomery Scott
-
Ashford (AINC) Prices 270K Share Common Offering at $74.50/Sh
-
Ashford Prices Public Offering Of Common Stock
-
Ashford (AINC) Announces Proposed $20M Common Share Public Offering
-
Ashford Launches Public Offering of Common Stock
-
Hercules Capital Closes Public Offering of $40.0 Million 6.25% Notes due 2033
-
UPDATE: Janney Downgrades Chesapeake Utilities (CPK) to Neutral
-
New Mountain Finance Corporation Announces Pricing of $50 Million of 5.75% Notes due 2023
-
U.S. bond market recession signal not far away, strategists say: Reuters poll
-
New Mountain Finance Corporation Announces Offering of Notes due 2023
-
Hercules Capital Prices Public Offering of $40 Million 6.25% Notes due 2033
-
INSYS Therapeutics to Present at Janney Healthcare Conference
-
Janney Remains Bullish on Global Blood Therapeutics (GBT) Voxelotor
-
Champions Oncology to Participate at the Janney Montgomery Scott Healthcare Conference 2018 in New York
-
Janney Montgomery Scott Starts Concert Pharmaceuticals (CNCE) at Neutral
-
Janney Montgomery Scott Starts Aldeyra Therapeutics (ALDX) at Buy
-
Monroe Capital Corporation Announces Closing of Public Offering of $69 Million 5.75% Notes Due 2023
-
Monroe Capital Corporation Announces Closing of Public Offering of $69 Million 5.75% Notes Due 2023
-
TapImmune To Present at 2018 Janney Healthcare Conference
-
B. Riley Financial Announces Closing of Senior Notes Offering
-
No News to Explain Agile Therapeutics' (AGRX) Wild Move - Janney
-
Provention Bio To Present at 2018 Janney Healthcare Conference
-
OncoCyte Corp (OCX) PT Doubled to $4 at Janney Montgomery Scott
-
Janney Remains Neutral on Acorda Therapeutics (ACOR)
-
BioDelivery Sciences to Present at the 2018 Janney Montgomery Scott Healthcare Conference
-
BioDelivery Sciences to Present at the 2018 Janney Montgomery Scott Healthcare Conference
-
UPDATE: Janney Upgrades SJW Group (SJW) to Buy
-
B. Riley Financial Announces Pricing of Senior Notes Offering
-
B. Riley Financial Announces Offering of $50 Million Senior Notes Due 2023 and Receipt of Investment Grade Rating of “A-” from Egan-Jones
-
Monroe Capital Corporation Prices Public Offering of $60 Million 5.75% Notes Due 2023
-
Monroe Capital Corporation Prices Public Offering of $60 Million 5.75% Notes Due 2023

